Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

INSERTION OF THE FATHER IN THE CARE OF THE HOSPITALIZED PRETERM INFANT: PERCEPTION OF THE MULTIPROFESSIONAL TEAM.

Soares NC, Bernardino MPL, Zani AV.

Rev Paul Pediatr. 2019 Jun 19;37(3):283-290. doi: 10.1590/1984-0462/;2019;37;3;00014. eCollection 2019. English, Portuguese.

2.

Glucosylceramides From Lomentospora prolificans Induce a Differential Production of Cytokines and Increases the Microbicidal Activity of Macrophages.

Xisto MIDDS, Henao JEM, Dias LDS, Santos GMP, Calixto ROR, Bernardino MC, Taborda CP, Barreto-Bergter E.

Front Microbiol. 2019 Mar 22;10:554. doi: 10.3389/fmicb.2019.00554. eCollection 2019.

3.

Ethnic Identity Development and Acculturation Preferences Among Minority and Majority Youth: Norms and Contact.

González R, Lickel B, Gupta M, Tropp LR, Luengo Kanacri BP, Mora E, De Tezanos-Pinto P, Berger C, Valdenegro D, Cayul O, Miranda D, Saavedra P, Bernardino M.

Child Dev. 2017 May;88(3):743-760. doi: 10.1111/cdev.12788. Epub 2017 Mar 20.

PMID:
28318013
4.

Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule.

Germar MJ, Purugganan C, Bernardino MS, Cuenca B, Chen YC, Li X, Van Kriekinge G, Lee IH.

Hum Vaccin Immunother. 2017 May 4;13(5):1158-1166. doi: 10.1080/21645515.2016.1269991. Epub 2017 Jan 11.

5.

Refractory epilepsy in children with brain tumors. The urgency of neurosurgery.

Bernardino MR, Funayama C, Hamad AP, Machado H, Sakamoto A, Thome U, Terra VC, Santos AC.

Arq Neuropsiquiatr. 2016 Dec;74(12):1008-1013. doi: 10.1590/0004-282X20160157. Erratum in: Arq Neuropsiquiatr. 2017 Apr;75(4):1.

6.

Oxalate nephropathy from cashew nut intake.

Bernardino M, Parmar MS.

CMAJ. 2017 Mar 13;189(10):E405-E408. doi: 10.1503/cmaj.151327. Epub 2016 Dec 12. No abstract available.

7.

What Do We Know About the Development of Creativity in South America?

Preiss DD, Grau V, Ortiz D, Bernardino M.

New Dir Child Adolesc Dev. 2016 Jun;2016(152):85-97. doi: 10.1002/cad.20157. Review.

PMID:
27254829
8.

Neonatal pityriasis versicolor.

Jubert E, Martín-Santiago A, Bernardino M, Bauzá A.

Pediatr Infect Dis J. 2015 Mar;34(3):329-30. doi: 10.1097/INF.0000000000000568. No abstract available.

PMID:
25742084
9.

Primary breast cancer of the vulva: a case report.

Diniz da Costa AT, Coelho AM, Lourenço AV, Bernardino M, Ribeirinho AL, Jorge CC.

J Low Genit Tract Dis. 2012 Apr;16(2):155-7. doi: 10.1097/LGT.0b013e31823b3bc6.

PMID:
22227843
10.

Effects of two different cycles of vagus nerve stimulation on interictal epileptiform discharges.

Santiago-Rodríguez E, Alonso-Vanegas M, Cárdenas-Morales L, Harmony T, Bernardino M, Fernández-Bouzas A.

Seizure. 2006 Dec;15(8):615-20. Epub 2006 Oct 17.

11.

Auditory steady-state responses in infants with perinatal brain injury.

Santiago-Rodríguez E, Harmony T, Bernardino M, Porras-Kattz E, Fernández-Bouzas A, Fernández T, Ricardo-Garcell J.

Pediatr Neurol. 2005 Apr;32(4):236-40.

PMID:
15797179
12.

Ultrastructural localization of glycoconjugates in Tritrichomonas foetus.

Benchimol M, Bernardino MV.

Parasitol Res. 2002 Feb;88(2):134-43.

PMID:
11936502
13.

A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis.

Small WC, DeSimone-Macchi D, Parker JR, Sukerkar A, Hahn PF, Rubin DL, Zelch JV, Kuhlman JE, Outwater EK, Weinreb JC, Brown JJ, de Lange EE, Woodward PJ, Arildsen R, Foster GS, Runge VM, Aisen AM, Muroff LR, Thoeni RF, Parisky YR, Tanenbaum LN, Totterman S, Herfkens RJ, Knudsen J, Bernardino ME, et al.

J Magn Reson Imaging. 1999 Jul;10(1):15-24.

PMID:
10398973
14.

Multisite study of the safety and efficacy of LumenHance, a new gastrointestinal contrast agent for MRI of the abdomen and pelvis.

Small WC, Macchi DD, Parker JR, Bernardino ME.

Acad Radiol. 1998 Apr;5 Suppl 1:S147-50; discussion S156. No abstract available.

PMID:
9561066
15.

Using physician work relative value units to profile surgical packages: methods and results for kidney transplant surgery.

Becker ER, Mauldin PD, Bernardino ME.

Best Pract Benchmarking Healthc. 1996 May-Jun;1(3):140-6.

PMID:
9192561
16.

Gadoteridol-enhanced MR imaging of malignant hepatic tumors: effects of triple versus standard doses on lesion-liver contrast.

Petersein J, Saini S, Mitchell DG, Davis PL, Johnson CD, Kuhlman JE, Parisky YR, Runge VM, Weinreb J, Bernardino ME, et al.

AJR Am J Roentgenol. 1995 Nov;165(5):1157-61.

PMID:
7572495
17.

Time versus density enhancement of liver, spleen, and great vessels following rapid intravenous infusion of perflubron emulsion.

Harned RK 2nd, Fruman SA, Swenson RB, Bernardino ME.

Acad Radiol. 1995 Jan;2(1):38-42.

PMID:
9419522
18.

Safety and optimum concentration of a manganese chloride-based oral MR contrast agent.

Bernardino ME, Weinreb JC, Mitchell DG, Small WC, Morris M.

J Magn Reson Imaging. 1994 Nov-Dec;4(6):872-6.

PMID:
7865949
19.

Perfluoroctyl bromide as a blood pool contrast agent for computed tomographic angiography.

Fruman SA, Harned RK 2nd, Marcus D, Kaufman S, Swenson RB, Bernardino ME.

Acad Radiol. 1994 Oct;1(2):151-3.

PMID:
9419479
20.

Cost-effective use of low-osmolality contrast media for CT of the liver: evaluation of liver enhancement provided by various doses of iohexol.

Bree RL, Parisky YR, Bernardino ME, Costello P, Leder R, Brown PC.

AJR Am J Roentgenol. 1994 Sep;163(3):579-83.

PMID:
8079849
21.

Does CTAP prior to hepatic resection improve patient survival rates?

Langmo LS, Dagher AP, Mehard WB, Small WC, Heiken JP, Fishman EK, Bernardino ME.

Abdom Imaging. 1994 Jul-Aug;19(4):317-9.

PMID:
8075553
22.

Contrast-enhanced spiral CT of the liver: effect of different amounts and injection rates of contrast material on early contrast enhancement.

Small WC, Nelson RC, Bernardino ME, Brummer LT.

AJR Am J Roentgenol. 1994 Jul;163(1):87-92.

PMID:
8010255
23.

Splenic magnetic resonance imaging using particulate agents.

Small WC, Nelson RC, Sherbourne GM, Bernardino ME.

Invest Radiol. 1994 Jun;29 Suppl 2:S12-4. No abstract available.

PMID:
7928204
24.

A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography.

Goldberg SN, Abrahams J, Drayer BP, Golding S, Bernardino M, Brunetti J.

Invest Radiol. 1994 May;29 Suppl 1:S76-83; discussion S93.

PMID:
8071050
25.

Enhancement effects of a hepatocyte receptor-specific MR contrast agent in an animal model.

Small WC, Nelson RC, Sherbourne GM, Bernardino ME.

J Magn Reson Imaging. 1994 May-Jun;4(3):325-30.

PMID:
8061429
26.

CT angiography and CT arterial portography in evaluation of hepatic adenomas.

Small WC, Chezmar JL, Bernardino ME.

J Comput Assist Tomogr. 1994 Mar-Apr;18(2):266-8.

PMID:
8126279
27.

Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.

Hamm B, Thoeni RF, Gould RG, Bernardino ME, Lüning M, Saini S, Mahfouz AE, Taupitz M, Wolf KJ.

Radiology. 1994 Feb;190(2):417-23.

PMID:
8284392
28.

Is the safety of contrast agents an issue in body computed tomography?

Bernardino ME.

Invest Radiol. 1993 Nov;28 Suppl 5:S68-70; discussion S71. Review.

PMID:
8282506
29.

Combined CT arterial portography and CT hepatic angiography for evaluation of the hepatic resection candidate. Work in progress.

Chezmar JL, Bernardino ME, Kaufman SH, Nelson RC.

Radiology. 1993 Nov;189(2):407-10.

PMID:
8210367
30.

Monitoring success of interventional therapy.

Bernardino ME.

Diagn Imaging (San Franc). 1993 Nov;Suppl:38-40. No abstract available.

PMID:
10146484
31.

Spiral methods create some practical problems.

Bernardino ME.

Diagn Imaging (San Franc). 1993 Nov;Suppl:15-6. No abstract available.

PMID:
10146481
32.
33.

Preoperative determination of the resectability of hepatic tumors: efficacy of CT during arterial portography.

Small WC, Mehard WB, Langmo LS, Dagher AP, Fishman EK, Heiken JP, Bernardino ME.

AJR Am J Roentgenol. 1993 Aug;161(2):319-22.

PMID:
8333369
34.

Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.

Rofsky NM, Weinreb JC, Bernardino ME, Young SW, Lee JK, Noz ME.

Radiology. 1993 Jul;188(1):53-9.

PMID:
8390072
35.

Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapy.

Redvanly RD, Chezmar JL, Strauss RM, Galloway JR, Boyer TD, Bernardino ME.

Radiology. 1993 Jul;188(1):283-5.

PMID:
8390070
36.

Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy. Work in progress.

Joseph FB, Baumgarten DA, Bernardino ME.

Radiology. 1993 Feb;186(2):553-6.

PMID:
8380650
37.

Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide.

Small WC, Nelson RC, Bernardino ME.

Magn Reson Imaging. 1993;11(5):645-54.

PMID:
8345779
38.

Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.

Bernardino ME, Young SW, Lee JK, Weinreb JC.

Radiology. 1992 Apr;183(1):53-8.

PMID:
1549694
39.

Comparison of iohexol 300 and diatrizoate meglumine 60 for body CT: image quality, adverse reactions, and aborted/repeated examinations.

Bernardino ME, Fishman EK, Jeffrey RB Jr, Brown PC.

AJR Am J Roentgenol. 1992 Mar;158(3):665-7.

PMID:
1739017
40.

The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT.

Jones EC, Chezmar JL, Nelson RC, Bernardino ME.

AJR Am J Roentgenol. 1992 Mar;158(3):535-9.

PMID:
1738990
41.
42.

Clinical hepatic imaging with paramagnetic positive enhancers.

Bernardino ME.

Magn Reson Med. 1991 Dec;22(2):334-8; discussion 343-6. No abstract available.

PMID:
1812367
43.

Randomized, double-blind comparison of Omnipaque 300 and Hypaque 60 in patients undergoing bolus-enhanced dynamic computed body tomography.

Brown PC, Bernardino ME, Fishman EK, Jeffrey RB Jr.

Invest Radiol. 1991 Nov;26 Suppl 1:S205-7; discussion S208. No abstract available.

PMID:
1808131
44.

Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease.

Bernardino ME, Young SW, Lee JK, Weinreb J.

Invest Radiol. 1991 Nov;26 Suppl 1:S148-9; discussion S150-5. No abstract available.

PMID:
1808113
45.

Diagnosis of pancreatic transplant dysfunction: value of gadopentetate dimeglumine-enhanced MR imaging.

Fernandez MP, Bernardino ME, Neylan JF, Olson RA.

AJR Am J Roentgenol. 1991 Jun;156(6):1171-6.

PMID:
2028861
46.

Manganese dipyridoxyl diphosphate. Effect of dose, time, and pulse sequence on hepatic enhancement in rats.

Nelson RC, Chezmar JL, Newberry LB, Malko JA, Gedgaudas-McClees RK, Bernardino ME.

Invest Radiol. 1991 Jun;26(6):569-73.

PMID:
1907259
47.

Renal transplant rejection. Limited value of duplex Doppler sonography.

Perchik JE, Baumgartner BR, Bernardino ME.

Invest Radiol. 1991 May;26(5):422-6.

PMID:
2055739
48.

Liver transplant biopsies with a biopsy gun.

Chezmar JL, Keith LL, Nelson RC, Plaire JC, Hertzler GL, Bernardino ME.

Radiology. 1991 May;179(2):447-8.

PMID:
2014290
49.

Hepatic dynamic sequential CT: section enhancement profiles with a bolus of ionic and nonionic contrast agents.

Nelson RC, Moyers JH, Chezmar JL, Hoel MJ, Jones EC, Peterson JE, Cork RD, Bernardino ME.

Radiology. 1991 Feb;178(2):499-502.

PMID:
1987614
50.

Percutaneous renal and adrenal biopsies.

Vassiliades VG, Bernardino ME.

Cardiovasc Intervent Radiol. 1991 Jan-Feb;14(1):50-4. Review.

PMID:
2044129

Supplemental Content

Loading ...
Support Center